Diagnostic values of metabolic syndrome definitions for detection of insulin resistance: Tehran lipid and glucose study (TLGS)

Archives of Iranian Medicine

Volumn 15, Issue 10, 2012, Pages 606-610

  Hosseinpanah, Farhad ^a   Borzooei, Shiva ^a   Barzin, Maryam ^a   Farshadi, Marjan ^a   Sarvghadi, Farzaneh ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Insulin resistance; Metabolic syndrome; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ADULT TREATMENT PANEL III; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; JOINT INTERIM STATEMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE;

EID: 84867260834     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocri-nol Metab. 1998; 83: 2773-2776.
2. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moor-jani S, et al. Hyperinsulinemia as an independent risk factor for isch-emic heart disease. N Engl J Med. 1996; 334: 952-957.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988; 37: 1595-1607.
4. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008; 28: 1039-1049.
5. Sierra-Johnson J, Johnson BD, Allison TG, Bailey KR, Schwartz GL, Turner ST. Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance. Diabetes Care. 2006, 29: 668-672.
6. Liao Y, Kwon S, Shaughnessy S. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004; 27: 978-983.
7. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Dia-betes. 2004; 53: 1195-1200.
8. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, He-dayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009; 10: 15.
9. Grundy SM, Hansen B, Smith SC Jr., Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004; 109: 551-556.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120: 1640-1645.
11. Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Dela-vari A, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010; 13: 243-244.
12. Mellitus. ECotDaCoD. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26(suppl 1): S5-S20.
13. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27: 1487-1495.
14. Ascott-Evans BH. The metabolic syndrome, insulin resistance and cardiovascular disease. SADJ. 2005; 60: 122-127.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.
16. Can AS, Bersot TP Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study BMC Public Health. 2007; 7: 353.
17. Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest. 2007; 37: 109-116.
18. Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiat-tarella P, et al. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Me-tabolism. 2008; 57: 355-361.
19. Esteghamati A, Ashraf H, Esteghamati AR, Meysamie A, Khalilzadeh O, Nakhjavani M, et al. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance. Diabetes Res Clin Pract. 2009; 84: 279-287.
20. Hadaegh F, Zabetian A, Sarbakhsh P, Khalili D, James WP, Azizi F Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes (Lond). 2009; 33: 1437-1445.
21. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32: 1092-1097.